Packaging
Borealis Bormed LE6609-PH puts high temperature sterilisation in the spotlight at Pharmapack 2010
Monday 25. January 2010 - Borealis, a leading provider of chemical and innovative plastics solutions, will feature Bormed LE6609-PH for pharmaceutical packaging for intravenous solutions and medicines at Pharmapack 2010 Stand D26 from February 1-2, 2010 in Paris.
The latest addition to its Bormed range of dedicated polyolefins for healthcare applications, Bormed LE6609-PH makes its first appearance at the annual Pharmapack event alongside the comprehensive film and moulded packaging innovations designed to meet the superior technical performance and challenging service requirements of the healthcare market.
Bormed is Borealis special healthcare product line offering 4 pillars: dedicated materials, additional support, security of supply and innovation. Bormed LE6609-PH was introduced to the market in mid- 2009, following the successful launch of LE6607-PH for soft and flexible bottles at Pharmapack 2009, to meet demands for greater security for sterilised products, reductions in material use and more efficient manufacturing.
This transparent, Blow Fill and Seal (BFS) low density polyethylene offers a high density level and therefore a high melting point. The resulting high steam sterilisation temperature allows converters to reduce autoclave residence time by up to 1.5 hours, speeding up their production cycle, lowering energy use and improving efficiency.
In addition, Bormed LE6609-PHs high density and optimised molecular weight distribution (MWD) offers the potential for material and weight reduction of up to 5-7%. Converters and brand owners can make more products of a lighter weight using the same material volume, while the resulting energy savings benefit both manufacturing costs and the environment.
With its Bormed family of dedicated polyolefins for the healthcare industry Borealis ensures a consistent, committed approach to material development for medical devices and pharmaceutical and diagnostic products. The polyethylene and polypropylene grades offer the security of supply, regulatory compliance, long-term traceability and reliability required by this highly-demanding, specialised sector.
Borealis EUR 50 million expansion of its Innovation Headquarters in Linz, Austria further reinforces its commitment to the industry. The latest plastics processing equipment, high-tech laboratories and the expertise of dedicated, international specialists are available at one single site, allowing faster and more customised product development tailored to the needs of the healthcare market.
“Patient safety is paramount to the healthcare industry and as a result product manufacturers require 100% confidence in materials, their regulatory compliance, and in the long-term support and technical capabilities of their suppliers,” comments Martyna Matelska-Jucha, Marketing Manager business unit Moulding. “Borealis Bormed materials and approach to R&D are focused on meeting these criteria. Using the latest development facilities at our Innovation Headquarters, dedicated production lines, global supply network and on-going customer support we are able to give the industry the peace of mind and performance capabilities it needs to bring safe, cutting-edge innovations to the market.”
Borealis Bormed materials are European Pharmacopeia (EP) and US Pharmacopeia compliant and are Drug Master File registered. In addition, most of the Bormed grades comply with biocompatibility standards as specified in ISO 10993.